1. Home
  2. NIKI

as of 10-29-2026 9:36am EST

$1.87
$0.05
-2.47%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.

Founded: 2010 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 1.5M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 11.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $1.78 - $10.39 Next Earning Date: 11-10-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 48.88%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: